These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8659100)

  • 1. Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription.
    Trujillo JM; Mounts P
    Virology; 1996 Jun; 220(1):1-9. PubMed ID: 8659100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.
    Stöppler MC; Straight SW; Tsao G; Schlegel R; McCance DJ
    Virology; 1996 Sep; 223(1):251-4. PubMed ID: 8806560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
    Liu Z; Ghai J; Ostrow RS; Faras AJ
    Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
    Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
    J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
    Vousden KH; Doniger J; DiPaolo JA; Lowy DR
    Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
    Pim D; Storey A; Thomas M; Massimi P; Banks L
    Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The products of the E5, E6, or E7 open reading frames of RhPV 1 can individually transform NIH 3T3 cells or in cotransfections with activated ras can transform primary rodent epithelial cells.
    Ostrow RS; Liu Z; Schneider JF; McGlennen RC; Forslund K; Faras AJ
    Virology; 1993 Oct; 196(2):861-7. PubMed ID: 8396814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation assays for HPV oncoproteins.
    Massimi P; Banks L
    Methods Mol Med; 2005; 119():381-95. PubMed ID: 16350412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of the E6 and E7 genes of human papillomavirus type 18 into human epithelial cells via recombinant retrovirus infection.
    Wu CJ; Chang KS; Chang YS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):123-34. PubMed ID: 10592818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activation by the E6 gene product of human papillomavirus type 16.
    Klingelhutz AJ; Foster SA; McDougall JK
    Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras.
    Liu Z; Ghai J; Ostrow RS; McGlennen RC; Faras AJ
    Virology; 1994 Jun; 201(2):388-96. PubMed ID: 8184549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
    Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
    Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
    Chen JJ; Hong Y; Androphy EJ
    Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
    Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells.
    Chen TM; Defendi V
    Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.
    Park NH; Gujuluva CN; Baek JH; Cherrick HM; Shin KH; Min BM
    Oncogene; 1995 Jun; 10(11):2145-53. PubMed ID: 7784058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells.
    Garbe J; Wong M; Wigington D; Yaswen P; Stampfer MR
    Oncogene; 1999 Apr; 18(13):2169-80. PubMed ID: 10327063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.